chartexchange

GHRS
GH Research PLC
stockNASDAQ

Market OpenNov 19, 2026 3:03:14 PM EST
18.18USD-0.384%(-0.07)162,942
15.16Bid20.59Ask5.43Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Dublin, Leinster, Ireland
Previous Close
$18.25
Beta
1.29
52-Week High
$31.44 2026-08-07
52-Week Low
$12.04 2025-12-16
SMA 50
$21.73
SMA 200
$21.73
Avg. Vol 10D
347,614
Avg. Vol 30D
338,433
Avg. Vol 90D
313,727
Relative Vol
0.47
50.91M
0.5300%
5,490
GHRS Profile

gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.

GHRS Performance
PeriodPriceDateChangeBeta
1W18.492026-11-12-1.57%2.298
1M18.282026-10-19-0.45%1.475
3M29.802026-08-19-38.93%1.314
6M21.942026-05-19-17.05%0.790
1Y14.382025-11-19+26.56%1.292
2Y9.612024-11-19+89.37%—
5Y25.812021-11-19-29.49%1.037
GHRS Stock Summary

GH Research PLC (NASDAQ:GHRS) stock price today is $18.20, and today's volume is 158,831. GHRS is down 0.281% today. The 30 day average volume is 338,433. GHRS market cap is $1.25B with 68.68M shares outstanding.